Orthostatic Hypotension

American Family Physician

Volumn 68, Issue 12, 2003, Pages 2393-2398

  Bradley, John G ^a,b   Davis, Kathy A ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Decatur Fam Pract Residency Prog ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; ANXIOLYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROMOCRIPTINE; BROMOCRIPTINE MESILATE; CANNABIS; DIURETIC AGENT; ERYTHROPOIETIN; FLUDROCORTISONE; INSULIN; MIDODRINE; MONOAMINE OXIDASE INHIBITOR; NARCOTIC AGENT; NITRIC ACID DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; PHENOTHIAZINE DERIVATIVE; PROAMITINE; SEDATIVE AGENT; SILDENAFIL; TRICYCLIC ANTIDEPRESSANT AGENT; VASODILATOR AGENT; VINCRISTINE; VINCRISTINE SULFATE;

ALGORITHM; AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM; BODY POSITION; BRAIN ISCHEMIA; CLINICAL FEATURE; CLINICAL TRIAL; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; DIFFERENTIAL DIAGNOSIS; FAMILY MEDICINE; FLUID INTAKE; GRAVITY; HEADACHE; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HEART RATE; HUMAN; HYPERTENSION; HYPOKALEMIA; HYPOMAGNESEMIA; HYPOVOLEMIA; INCREASED APPETITE; MEDICAL SOCIETY; MYDRIASIS; NEUROLOGIC DISEASE; NONHUMAN; ORTHOSTATIC HYPOTENSION; PARESTHESIA; PATHOPHYSIOLOGY; PRESSORECEPTOR; PRURITUS; REFLEX; REVIEW; SALT INTAKE; SIDE EFFECT; STANDING; SYSTOLIC BLOOD PRESSURE; TREATMENT INDICATION; VENOUS RETURN; WEIGHT GAIN; WELLBEING;

DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPOTENSION, ORTHOSTATIC;

EID: 0347363557     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology, Neurology 1996;46:1470.
2. Petersen ME, Williams TR, Gordon C, Chamberlain-Webber R, Sutton R. The normal response to prolonged passive head up tilt testing. Heart 2000;84:509-14.
3. Sumiyoshi M, Mineda Y, Kojima S, Suwa S, Nakata Y. Poor reproducibility of false-positive tilt testing results in healthy volunteers. Jpn Heart J 1999;40:71-8.
4. Mader SL, Josephson KR, Rubenstein LZ. Low prevalence of postural hypotension among community-dwelling elderly. JAMA 1987;258:1511-4.
5. Ooi WL, Barrett S, Hossain M, Kelley-Gagnon M, Lipsitz LA. Patterns of orthostatic blood pressure change and their clinical correlates in a frail, elderly population. JAMA 1997;277:1299-304.
6. Rutan GH, Hermanson B, Bild DE, Kittner SJ, LaBaw F, Tell GS. Orthostatic hypotension in older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. Hypertension 1992;19:508-19.
7. Eigenbrodt ML, Rose KM, Couper DJ, Arnett DK, Smith R, Jones D. Orthostatic hypotension as a risk factor for stroke: the atherosclerosis risk in communities (ARIC) study, 1987-1996. Stroke 2000;31:2307-13.
8. Lipsitz LA. Orthostatic hypotension in the elderly. N Engl J Med 1989;321:952-7.
9. Weiling W, VanLieshout JJ. Maintenance of postural normotension in humans. In: Low PA. Clinical autonomic disorders: evaluation and management. Boston: Little, Brown, 1993:69-77.
10. Low PA, Opfer-Gehrking TL, McPhee BR, Fealey RD, Benarroch EE, Willner CL, et al. Prospective evaluation of clinical characteristics of orthostatic hypotension. Mayo Clin Proc 1995;70:617-22.
11. Grubb BP, Karas B. Clinical disorders of the autonomic nervous system associated with orthostatic intolerance: an overview of classification, clinical evaluation, and management. Pacing Clin Electrophysiol 1999;22:798-810.
12. Mathias CJ. Orthostatic hypotension: causes, mechanisms, and influencing factors. Neurology 1995;45(4 suppl 5):S6-11.
13. Hollister AS. Orthostatic hypotension: causes, evaluation, and management. West J Med 1992;157:652-7.
14. Robertson D, Davis TL. Recent advances in the treatment of orthostatic hypotension. Neurology 1995;45(4 suppl 5):S26-32.
15. Engstrom JW, Aminoff MJ. Evaluation and treatment of orthostatic hypotension. Am Fam Physician 1997;56:1378-84.
16. Harrison TR, Brunwald E. Harrison's Principles of internal medicine. 15th ed. New York: McGraw-Hill, 2001.
17. Low PA, Gilden JL, Freeman R, Sheng KN, McElligott MA. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group. [Published erratum appears in JAMA 1997;278:388]. JAMA 1997;277:1046-51.
18. Low PA, Gilden JL, Freeman R, Sheng KN, McElligott MA. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group. [Published erratum appears in JAMA 1997;278:388]. JAMA 1997;277:1046-51.
19. Hoeldtke RD, Streeten DH. Treatment of orthostatic hypotension with erythropoietin. N Engl J Med 1993;329:611-5.